Skip to main content
. Author manuscript; available in PMC: 2013 May 3.
Published in final edited form as: Clin Lung Cancer. 2011 May 17;12(6):369–374. doi: 10.1016/j.cllc.2011.02.002

Figure 2.

Figure 2

Box plots demonstrating the distribution of biomarkers by histologic subtype NSCLC versus sarcomatoid lung cancer. The white cross demonstrating the mean immunohistochemical (IHC) score and the white bar indicating the median IHC score by (A) a statistically significant difference by Wilcoxon rank sum test in PDGFRβ IHC (p<0.0001) and no significant difference in (B) PDGF-B IHC (p=0.16).